• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Juha Kinnunen

Analyst

Juha Kinnunen portrait

Coverage

Detection TechnologyFondiaFortumAspocomp GroupBittiumRevenio GroupTalenomOptomed

Latest content

ShowingAll content types

Fondia Q2'26 preview: Medvind på transaktionsmarkedet og en trimmet omkostningsstruktur understøtter resultatet

Analyst Comment 18.08.2026, 06.30 by Juha Kinnunen
Fondia

Revenio: iCare's AI partner received green light from FDA

Analyst Comment 17.08.2026, 09.52 by Juha Kinnunen
Revenio Group

Optomed Q2'26: Salget af udstyr halter, men de løbende indtægter vokser

Research 17.08.2026, 07.00 by Juha Kinnunen
Optomed

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Talenom Q2'26: Unpleasant surprise in Spain clouded many positives

Research 14.08.2026, 17.37 by Juha Kinnunen
Talenom

Der blev fremsat et købstilbud på Detection Technologys konkurrent Varex med en betydelig præmie

Analyst Comment 11.08.2026, 08.31 by Juha Kinnunen
Detection Technology

Optomed Q2'26 preview: Vi forventer tilbagevenden til vækst og overvåger pengestrømmen

Analyst Comment 11.08.2026, 07.02 by Juha Kinnunen
Optomed

Talenom Q2'26 preview: Spain boosts growth as new costs weigh on earnings

Analyst Comment 10.08.2026, 08.50 by Juha Kinnunen
Talenom

Bittium Q2'26: Kun betydelige nye åbninger mangler

Research 10.08.2026, 07.00 by Juha Kinnunen
Bittium

Bittium Q2'26 - kort kommentar: Stærke forsvarsleverancer og -ordrer overgik forventningerne klart

Analyst Comment 07.08.2026, 08.01 by Juha Kinnunen
Bittium

Detection Technology Q2'26: Regnskab og aktiekurs på forskellige spor

Research 07.08.2026, 07.00 by Juha Kinnunen
Detection Technology